CoChat

Targeting IFN-α to B Cell Lymphoma by a Tumor-Specific Antibody Elicits Potent Antitumor Activities

Huang, Tzu-Hsuan, Chintalacharuvu, Koteswara R, Morrison, Sherie L · 2007 · The Journal of Immunology
Cited by 51

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

IFN-α, a cytokine crucial for the innate immune response, also demonstrates antitumor activity. However, use of IFN-α as an anticancer drug is hampered by its short half-life and toxicity. One approach to improving IFN-α’s therapeutic index is to increase its half-life and tumor localization by fusing it to a tumor-specific Ab. In the present study, we constructed a fusion protein consisting of anti-HER2/neu-IgG3 and IFN-α (anti-HER2/neu-IgG3-IFN-α) and investigated its effect on a murine B cell lymphoma, 38C13, expressing human HER2/neu. Anti-HER2/neu-IgG3-IFN-α exhibited potent inhibition of 38C13/HER2 tumor growth in vivo. Administration of three daily 1-μg doses of anti-HER2/neu-IgG3-IFN-α beginning 1 day after tumor challenge resulted in 88% of the mice remaining tumor free. Remarkably, anti-HER2/neu-IgG3-IFN-α demonstrated potent activity against established 38C13/HER2 tumors, with complete tumor remission observed in 38% of the mice treated with three daily doses of 5 μg of the fusion protein (p = 0.0001). Ab-mediated targeting of IFN-α induced growth arrest and apoptosis of lymphoma cells contributing to the antitumor effect. The fusion protein also had a longer in vivo half-life than rIFN-α. These results suggest that IFN-α Ab fusion proteins may be effective in the treatment of B cell lymphoma.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.179.10.6881

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

Metadata

Authors
Huang, T.-H., Chintalacharuvu, K. R., & Morrison, S. L.
Venue
The Journal of Immunology
Published
2007-11
Volume
179
Issue
10
Pages
6881-6888
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W2141716239
Cited by
51
References
2
FWCI
1.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.